Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 2;23(21):13388.
doi: 10.3390/ijms232113388.

Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands

Affiliations

Potential of Vitamin B6 Dioxime Analogues to Act as Cholinesterase Ligands

Dajana Gašo Sokač et al. Int J Mol Sci. .

Abstract

Seven pyridoxal dioxime quaternary salts (1-7) were synthesized with the aim of studying their interactions with human acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The synthesis was achieved by the quaternization of pyridoxal monooxime with substituted 2-bromoacetophenone oximes (phenacyl bromide oximes). All compounds, prepared in good yields (43-76%) and characterized by 1D and 2D NMR spectroscopy, were evaluated as reversible inhibitors of cholinesterase and/or reactivators of enzymes inhibited by toxic organophosphorus compounds. Their potency was compared with that of their monooxime analogues and medically approved oxime HI-6. The obtained pyridoxal dioximes were relatively weak inhibitors for both enzymes (Ki = 100-400 µM). The second oxime group in the structure did not improve the binding compared to the monooxime analogues. The same was observed for reactivation of VX-, tabun-, and paraoxon-inhibited AChE and BChE, where no significant efficiency burst was noted. In silico analysis and molecular docking studies connected the kinetic data to the structural features of the tested compound, showing that the low binding affinity and reactivation efficacy may be a consequence of a bulk structure hindering important reactive groups. The tested dioximes were non-toxic to human neuroblastoma cells (SH-SY5Y) and human embryonal kidney cells (HEK293).

Keywords: AChE; BChE; cytotoxicity; dioxime; molecular docking; pyridoxal oxime; reactivation; reversible inhibition.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
A general schematic representation of the preparation of pyridoxal dioximes.
Figure 1
Figure 1
The chemical structures of the tested pyridoxal dioximes 17 and medically approved oxime HI-6.
Figure 2
Figure 2
Schematic presentation of the SN1 mechanism occurring in pyridoxal dioxime synthesis.
Figure 3
Figure 3
Enumeration scheme for the assignment of the NMR spectra when R=H, F, Cl, Br, NO2, OCH3, or phenyl.
Figure 4
Figure 4
Part of the 1H-13C HMBC spectra (600 MHz, DMSO-d6) of 3. The ovals indicate cross peaks, important for the assignment and confirmation of the synthesized compound. The part of the 1H NMR spectrum is shown at the top and part of the 13C NMR spectrum is shown at the left edge.
Figure 5
Figure 5
Physicochemical characteristics (molecular weight (M), number of hydrogen bond donors and acceptors (HBDs and HBAs), number of rotating bonds (RBs), lipophilicity (logP), and topological polar surface area (TPSA)) of pyridoxal dioximes in relation to the reference literature values given by the red dashed line [30].
Figure 6
Figure 6
Close-up of the active site of the model complexes between AChE and compound 1 (A) or 7 (B) and BChE and compound 7 (C). Dashed lines represent different types of non-bonding interactions. Red spheres represent conserved water molecules. For clarity, only water molecules predicted to be engaged in non-bonding interactions are shown.

Similar articles

Cited by

References

    1. Timperley C., Forman J., Abdollahi M., Al-Amri A., Alonso I., Baulig A., Borrett V., Cariño F., Curty C., Gonzalez D., et al. Advice from the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons on isotopically labelled chemicals and stereoisomers in relation to the Chemical Weapons Convention. Pure Appl. Chem. 2018;90:1647–1670. doi: 10.1515/pac-2018-0803. - DOI
    1. Darvesh S., Hopkins D.A., Geula C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 2003;4:131–138. doi: 10.1038/nrn1035. - DOI - PubMed
    1. Li B., Stribley J.A., Ticu A., Xie W., Schopfer L.M., Hammond P., Brimijoin S., Hinrichs S.H., Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J. Neurochem. 2000;75:1320–1331. doi: 10.1046/j.1471-4159.2000.751320.x. - DOI - PubMed
    1. Zorbaz T., Malinak D., Hofmanova T., Maraković N., Žunec S., Maček Hrvat N., Andrys R., Psotka M., Zandona A., Svobodova J., et al. Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents. Eur. J. Med. Chem. 2022;238:114377. doi: 10.1016/j.ejmech.2022.114377. - DOI - PubMed
    1. Semenov V.E., Zueva I.V., Mukhamedyarov M.A., Lushchekina S.V., Petukhova E.O., Gubaidullina L.M., Krylova E.S., Saifina L.F., Lenina O.A., Petrov K.A. Novel acetylcholinesterase inhibitors based on uracil moiety for possible treatment of Alzheimer disease. Molecules. 2020;25:4191. doi: 10.3390/molecules25184191. - DOI - PMC - PubMed